International Circulation:New clinical trials and registry studies have showed that the benefit of drug-eluting stents in terms of restenosis is not achieved at the expense of a compromised safety. What’s your opinion on the issue? Do you think the controversy over the safety of DES compared to BMS could be settled by current data?《国际循环》：新的临床试验和注册研究结果已经显示，因为安全性的问题，药物洗脱支架（DES）没有取得对再狭窄的益处。请问您对这一问题的看法如何？您认为当前的研究数据能够解决DES相对于裸金属支架（BMS）的安全性争论吗？
International Circulation: Talking about PCI in treating multi-vessel coronary disease， what is the optimal approach to achieve benefits as big as possible in your opinion?
《国际循环》：PCI治疗多血管冠脉病变时，请问您的观点，获得最大益处的最佳方案是什么？
Mark Turco: You need to individualize your approach to treating multi-vessel disease. Not all multi-vessel disease is the same. Clinicians need to look at the angiogram and derive a SYNTAX score out of the angiogram and then decide what therapies are going to be in the patients’ best interests. If I have three lesions in three different vessels t
京公网安备 11010502033353号